Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From OncoCyte Corporation
During Q2, biopharmas brought in an aggregate $12.5bn in financing and device company fundraising totaled $3.7bn; while in vitro diagnostic firms and research tools players raised $720m.
Deal Snapshot: Pharma places $30m upfront wager on biotech’s allogeneic natural killer cell and chimeric antigen receptor technologies, with hopes for solid tumor cell therapies.
- Diagnostic Equipment & Supplies
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Other Names / Subsidiaries
- BioTime, Inc.
- Chronix Biomedical
- Insight Genetics
- Razor Genomics